Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-23-026522

Chief Financial Officer sold 721 shares at $9.88 ($7,121)

  • Chief Financial Officer acquired 2,886 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

van Houte Hans · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-04-30 Exercise or conversion : show line 1 in the form +2,886 79,651 D
2023-05-01 Sale : show line 2 in the form −721 $9.88 $7,121 78,930 D
Open-market sales · 721 sh · avg $9.88 · $7,121

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −2,886 31,747 D
Loading xslF345X04/doc4.xml…